Mutations in the human LMNA gene cause muscular dystrophy by mechanisms that are incompletely understood. The LMNA gene encodes A-type lamins, intermediate filaments that form a network underlying the inner nuclear membrane, providing structural support for the nucleus and organizing the genome. To better understand the pathogenesis caused by mutant lamins, we performed a structural and functional analysis on LMNA missense mutations identified in muscular dystrophy patients. These mutations perturb the tertiary structure of the conserved A-type lamin Ig-fold domain. To identify the effects of these structural perturbations on lamin function, we modeled these mutations in Drosophila Lamin C and expressed the mutant lamins in muscle. We found that the structural perturbations had minimal dominant effects on nuclear stiffness, suggesting that the muscle pathology was not accompanied by major structural disruption of the peripheral nuclear lamina. However, subtle alterations in the lamina network and subnuclear reorganization of lamins remain possible. Affected muscles had cytoplasmic aggregation of lamins and additional nuclear envelope proteins. Transcription profiling revealed upregulation of many Nrf2 target genes. Nrf2 is normally sequestered in the cytoplasm by Keap-1. Under oxidative stress Nrf2 dissociates from Keap-1, translocates into the nucleus, and activates gene expression. Unexpectedly, biochemical analyses revealed high levels of reducing agents, indicative of reductive stress. The accumulation of cytoplasmic lamin aggregates correlated with elevated levels of the autophagy adaptor p62/SQSTM1, which also binds Keap-1, abrogating Nrf2 cytoplasmic sequestration, allowing Nrf2 nuclear translocation and target gene activation. Elevated p62/SQSTM1 and nuclear enrichment of Nrf2 were identified in muscle biopsies from the corresponding muscular dystrophy patients, validating the disease relevance of our Drosophila model. Thus, novel connections were made between mutant lamins and the Nrf2 signaling pathway, suggesting new avenues of therapeutic intervention that include regulation of protein folding and metabolism, as well as maintenance of redox homoeostasis.
The human LMNA gene exemplifies the rich source of genetic variation that exists in the human genome. Over 283 sequence variants and 460 disease-causing mutations have been identified to date. These mutations cause at least 13 distinct clinical diseases, called laminopathies, which have mainly tissue-restricted phenotypes, despite the fact that A-type lamins are expressed in nearly all cells [1]. For any given disease, mutations are scattered throughout the LMNA gene [2]. Furthermore, neighboring missense mutations can give rise to dramatically different disease phenotypes. These findings suggest that defined protein domains do not have tissue-specific functions. The LMNA gene encodes alternatively spliced mRNAs for lamin A and C that have a common domain structure [3]. The N-terminal region of lamins forms a globular domain, the central region forms a coiled coil domain, and the carboxy terminus contains an Ig-fold domain [4]. Lamins dimerize through the rod domain and form filaments via head-to-tail interactions of the dimers. Lateral interactions between lamin filaments are thought to generate higher order structures that form the network that underlies the inner membrane of the nuclear envelope. This network provides structural stability to the nucleus, serves as a scaffold for inner nuclear envelope proteins, and organizes the genome through contacts made with chromatin [5]. The mechanisms by which mutant lamins cause disease remain incompletely understood. It has been proposed that mutant lamins cause nuclear fragility, leading to nuclear deformation and breakage under mechanical stress [6]. This idea provides an explanation for the tissue-restricted phenotypes associated with muscular dystrophy and cardiomyopathy. However, sensitivity to mechanical stress does not explain why mutant lamins cause other diseases, such as lipodystrophy. For tissues that do not experience mechanical stress, mutant lamins are proposed to dysregulate gene expression [7]. While evidence exists for both the mechanical stress and gene expression models, it is also possible that lamins are required for adult stem cell homeostasis [8]. To gain novel insights into mechanisms by which mutant lamins cause disease, we previously developed a Drosophila model of lamin associated muscular dystrophy [9]. Mutations identified in patients are modeled into Drosophila Lamin C. Tissue-specific expression achieved by the Gal4/UAS system provides a means of expressing the mutant lamins in desired tissues [10]. Expression of the mutant lamins in larval body wall muscle causes larval locomotion defects and pupal death [9]. Here, we report in-depth structural and functional analyses of the mutant lamins identified in muscular dystrophy patients. Structural studies, which included NMR analysis, showed that the pathogenic mutations perturb the tertiary structure of the lamin Ig-fold domain. These structural perturbations are associated with cytoplasmic lamin aggregation, activation of the Nrf2/Keap-1 pathway, and reductive stress, yet have minimal effects on nuclear stiffness. These data lead to a novel hypothesis suggesting that cytoplasmic aggregation of nuclear envelope proteins causes Nrf2 target gene activation. Our findings provide new potential avenues for therapy involving protein metabolism and redox homeostasis.
To identify mechanisms by which LMNA mutations cause muscle disease, we performed an in-depth structural analysis on four mutations identified in patients with skeletal muscular dystrophy. Each patient possessed a single nucleotide substitution in LMNA that caused an amino acid substitution in the Ig-fold domain of A-type lamins. These amino acid substitutions (G449V, N456I, L489P and W514R) were dispersed throughout the Ig-fold domain and map to loop regions, making their effect on protein structure challenging to predict (S1 Fig). To analyze the effects of these amino acid substitutions on Ig-fold structure, sequences encoding the wild type and mutant human A-type lamin Ig-fold domain were cloned into an expression vector, expressed and purified from E. coli (S2A Fig). The peptides were analyzed by circular dichroism (CD) and NMR. The wild type A-type lamin Ig-fold domain contains eight anti-parallel and one parallel beta strands that form a beta barrel structure [11] (S1 Fig). The CD spectra for the wild type and three of the mutant Ig-fold domains showed similar peak intensity at 220 nm (S2B Fig) demonstrating that the beta-sheet content of the wild type and mutant Ig-fold domains was comparable. Given the absence of obvious changes in beta sheet content between the wild type and mutant Ig-fold domains, we examined whether the amino acid substitutions altered the tertiary structure of the Ig-fold domain. Changes in tertiary structure often affect the thermal stability of a protein. We determined the T1/2 for denaturation of the wild type Ig-fold to be 55°C (S2C Fig), which was slightly lower than the published value of 62°C [11]. This variation might be accounted for by slight differences in the size of the domain in the expression constructs. Our construct included amino acid residues 435–552, whereas the published construct included amino acid residues 411–553 [11]. The T1/2 values for denaturation of G449V, N456I and W514R were reduced to 40,35 and 35°C, respectively (S2C Fig). Thus, all three of the mutants analyzed had significantly lowered the thermal stability of the Ig-fold compared to that of the wild type Ig-fold domain. In the absence of changes in secondary structure, a lower T1/2 value for thermal stability for the mutant proteins suggested structural perturbations (i. e. altered positioning of amino acids) within the Ig-fold domain tertiary structure. The 15N/1H Heteronuclear Single Quantum Coherence (HSQC) NMR spectrum of the wild type Ig-fold domain of our construct showed well dispersed cross peaks, similar to those reported, indicating that the wild type protein is well folded and has similar tertiary structures as reported previously [11] (S3A Fig). However, subtle differences are clearly observed between the two 15N/1H HSQC spectra, due to differences in the expression constructs used (see above). To determine whether the amino acid substitutions caused changes in the tertiary structure of the Ig-fold domain, we assigned the backbone amide cross peaks in the 15N/1H HSQC spectrum of the wild type Ig-fold (S3B Fig) and compared it to that generated from the 15N/1H HSQC spectrum of each mutant (Fig 1A). All mutants showed significant changes in the 15N/1H HSQC spectrum. In all cases, perturbations were observed in the loop in which the amino acid substitution occurred. In addition, G449V and W514R showed chemical shift perturbations throughout the beta sheets of the Ig-fold domain, indicating that these two mutations caused large structural changes. Among the four mutants tested, N456I exhibited a spectrum most similar to that of the wild type Ig-fold, while the L489P mutant showed a mixed population of folded and unfolded protein. Analysis of the chemical shift perturbation data revealed two clusters of commonly perturbed residues, one shared between G449V and W514R (Fig 1B) and other shared between N456I and L489P (Fig 1C). These commonly perturbed residues are on opposite sides of the Ig-fold barrel (Fig 1C). Taken together, our analysis identified two surfaces on the Ig-fold that are critical for the function of A-type lamins in muscle. Lamins A and C are contributors to nuclear stiffness [12,13]. Given the structural perturbations of the mutant Ig-fold domains, we tested whether full-length lamins possessing the amino acid substitutions within the Ig-fold altered nuclear deformation in response to mechanical stress. To accomplish this, we made use of a Drosophila model [9]. Drosophila Lamin C shows conservation of amino acid sequence and domain organization with human lamin A/C, including the amino acid residues under investigation [9]. Note that the amino acid numbering for the substituted residues is different between the human and Drosophila Ig-fold (S1 Fig) due to differences in the size of the domain between the two species. Importantly, the carboxyl sequence of Drosophila Lamin C is predicted to form an Ig-fold structure that is highly similar to that of human lamin A (S4 Fig). In addition, the spatial and temporal expression pattern of Drosophila Lamin C is conserved with that of human lamin A/C [14]. Mutations identified in human LMNA were modeled into the Drosophila Lamin C gene, transgenic Drosophila were generated and the Gal4/UAS system [10] was used to express wild type and mutant lamins in Drosophila larval body wall muscle at levels comparable to endogenous Lamin C [9]. Expression of wild type Drosophila Lamin C in the larval body wall muscle caused no obvious phenotypes and did not affect viability [9]. In contrast, muscle-specific expression of mutant Lamin C caused larval locomotion defects and semi-lethality at the pupal stage [9]. Approximately 30% of the larval body wall muscles showed abnormally shaped and spaced nuclei, disorganization of the actin cytoskeleton, and cytoplasmic aggregation of nuclear envelope proteins including mutant Lamin C (Fig 2A) and nuclear pore proteins as shown previously [9]. None of these cellular phenotypes were observed in the wild type Lamin C control where lamin localization was confined to the nucleus (Fig 2A). To examine the effect of mutant lamins on nuclear stability in muscle tissue, larval body wall muscle fillets were hand-dissected from transgenic Drosophila larvae and attached to a flexible silicone membrane for nuclear strain measurements [13]. Expression of wild type Lamin C in an otherwise wild type background did not alter nuclear stiffness relative to that of a non-transgenic stock (Fig 2B). In contrast, expression of Lamin C in which the N-terminal head domain had been deleted (ΔN) showed larger nuclear deformation (Fig 2A) corresponding to decreased nuclear stiffness (Fig 2B). These results are consistent with the dominant negative effects observed for headless lamin A in the cultured cells [13]. No statistical difference in nuclear tension was observed in myonuclei expressing wild type and mutant Lamin C. Thus, these show that the mutant lamins do not have dominant effects on the nuclear tension in Drosophila muscle fibers. In the absence of dominant changes in nuclear stiffness, we reasoned that mutant lamins might exert their pathogenic effects by changing muscle gene expression [15–17]. To minimize indirect effects on gene expression, we exploited the Drosophila model to capture changes in muscle gene expression 24–48 hours following induction of mutant Lamin C expression. Total RNA was isolated from larval body wall muscles and used for Affymetrix gene expression profiling. The analysis was performed on transgenic larvae expressing wild type, ΔN and G489V full-length versions of Lamin C. Lamin C ΔN was selected because it is known to have dominant negative effects on lamin assembly. Lamin C G489V was selected because it caused the greatest percent lethality (95%) [9]. Using the Partek software suite and a two-fold cut off with a p value of 0. 05 or greater, 28 genes showed changes in expression between muscle expressing wild type Lamin C and ΔN (Fig 3A and S1 Table). A total of 87 genes showed changes in expression between wild type Lamin C and the G489V mutant (Fig 3A and S2 Table), with 21 genes overlapping with those altered by the ΔN mutant (Fig 3A and Table 1). The majority of these genes were up-regulated in response to the mutant lamins, consistent with a repressive role of wild type lamins in gene expression [15,16]. The relatively small number of genes that changed expression is consistent with the idea that ‘first responder’ genes were captured by the analysis. Using Partek and Flybase gene annotations, we discovered that cellular detoxification genes, such as glutathione S transferase (Gst) genes, were enriched among those that changed expression (Table 2). These genes are typically activated in response to oxidative stress [18,19]. Other genes, including those involved in neuromuscular junction function (Table 2, S1 and S2 Tables) might be activated to compensate for deterioration of the muscles at the neuromuscular junction. Thus, the gene expression analysis provided insights on the initial stages of pathogenesis. Cellular anti-oxidant genes are typically activated in response to a redox imbalance. Measurements of the levels of oxidized (GSSG) and reduced (GSH) glutathione were determined in extracts from body wall muscles from larvae expressing wild type, ΔN and G489V Lamin C transgene. This revealed similar levels of GSSG among all genotypes (Fig 3C, left panel). In contrast, GSH levels were elevated in muscle expressing the mutant Lamin C relative to wild type (Fig 3C, middle panel). Elevated levels of GSH and NADPH are hallmarks of a condition known as ‘reductive stress’ [20]. We found that NADPH levels were also elevated in the muscle of the larvae expressing ΔN and G489V, relative to wild type Lamin C (Fig 3C, right panel). These findings demonstrate that mutant lamins cause reductive stress in muscle. To identify the source of the reductive stress, we measured the activity of NADPH-producing enzymes in larval body wall muscle. We discovered that the activity of glucose-6-phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydrogenase (6PGH) were similar between muscles expressing wild type and mutant Lamin C (S5 Fig, left and middle panel). In contrast, the activity of isocitrate dehydrogenase (IDH) was elevated in muscles expressing mutant lamins, compared to that of wild type (S5 Fig, right panel). Thus, the elevated IDH activity provides a potential explanation for the increased levels of NADPH. Genes involved in cellular detoxification, such as the Gst genes, are typically activated by the conserved Nuclear factor erythroid 2-related factor 2 (Nrf2) /Kelch-like ECH associated protein 1 (Keap-1) signaling pathway [21,22]. Under normal conditions, the antioxidant transcription factor Nrf2 is sequestered in the cytoplasm by Keap-1. Under conditions of oxidative stress, cysteine residues within Keap-1 are oxidized, causing Nrf2 to no longer associate and translocate into the nucleus, where it activates target genes possessing anti-oxidant response elements (AREs) [21,22]. However, an alternative mechanism for Nrf2 target gene activation has been described for conditions of reductive stress [23] (Fig 3B). This mechanism relies on the competition between Nrf2 and p62/SQSTM1, an autophagy cargo acceptor, for the binding of Keap-1. Increased levels of p62/SQSTM1 sequester Keap-1, allowing Nrf2 to translocate into the nucleus and activate target genes. Our finding that cellular detoxification genes were upregulated in response to mutant lamins suggested that the Nrf2/Keap-1 pathway was activated. To determine if this was the case, we performed immunohistochemistry on larval body wall muscle expressing wild type and mutant Lamin C with antibodies to Cap-and-collar C (CncC), the Drosophila homologue of Nrf2 [24]. In muscles expressing wild type Lamin C, we observed little to no staining, consistent with the fact that Nrf2/Keap-1 is rapidly turned over under normal conditions (Fig 4A) [25]. In contrast, we observed enhanced nuclear staining in muscles expressing each of the mutant Lamin C, relative to controls (Fig 4A). Thus, mutant lamins cause nuclear accumulation of CncC (Nrf2), which is consistent with activation of the Nrf2/Keap-1 pathway and expression of many CncC target genes. To determine if the Nrf2/Keap-1 pathway is active in the human disease state, we stained muscle biopsy tissues from patients (possessing the mutations that were modeled in Drosophila) with antibodies to human Nrf2 [24]. In control muscle tissue, little to no staining was observed with the Nrf2 antibody (Fig 4B). In contrast, enhanced staining within the myonuclei of the patient muscle biopsy tissue was apparent (Fig 4B). Thus, expression of mutant lamins correlates with nuclear translocation of Nrf2 in both Drosophila and diseased human muscle. In mammalian systems Nrf2 and p62/SQSTM1 are co-regulated [21]. Given our findings of reductive stress and Nrf2 myonuclei enrichment, we hypothesized that levels of the autophagy cargo protein p62/SQSTM1 would be elevated in the muscles expressing mutant lamins relative to controls. To test this hypothesis, we stained Drosophila larval body wall muscles with antibodies to Drosophila p62/Ref (2) P, a homologue of human p62/SQSTM1 [26]. Muscles expressing wild type Lamin C showed hardly any staining for p62/Ref (2) P (Fig 5A). In contrast, muscles expressing mutant lamins showed increased cytoplasmic foci of staining (Fig 5A). The elevated levels of p62/Ref (2) P were validated by western analysis of protein extract from larval body wall muscles (S6 Fig). Thus, mutant lamins cause elevated levels of cytoplasmic p62/Ref (2) P, which is consistent with the increased cytoplasmic aggregation of mutant lamins (Fig 2A). To determine if the elevated levels of p62/Ref (2) P also occur in the human disease state, we stained muscle biopsy samples from the patients (possessing the mutations that were modeled in Drosophila) with antibodies to human p62/SQSTM1 [26]. Scoring muscle fibers positive for p62/SQSTM1 if they had ten or more visible foci containing p62/SQSTM1, showed that the control patient muscle tissue had low levels of p62/SQSTM1; only 5/200 muscle fibers were positive (Fig 5B). In contrast, 48–62/200 fibers were scored positive in the patient samples. Furthermore, the diameter of the p62/SQSTM foci in the patient tissues was larger than those in the controls (Fig 5B). These findings strongly suggest that the Nrf2/Keap-1 pathway activation in both Drosophila and human muscle occurs through an alternative mechanism that is triggered by elevated levels of p62/SQSTM1.
Our structural studies of the lamin Ig-fold demonstrated that single amino acid substitutions in the loop regions perturb the tertiary structure, leaving the secondary structure of the folded domain largely intact (S2 Fig). These data were consistent with single-molecule force spectroscopy showing that the lamin Ig-fold possessing an R453W substitution required less force to unfold than the wild type Ig-fold domain [27]. Our structural data are consistent with in silico modeling in which amino acid substitutions in the Ig-fold that cause muscular dystrophy were predicted to alter the structure, more so than those that cause lipodystrophy or progeria [28]. Our NMR analysis of the mutant Ig-fold domains identified surfaces on opposite sides of the Ig-fold barrel that are critical for muscle function. This finding predicts that substitution of other amino acids that comprise these surfaces might result in muscular dystrophy. Consistent with this prediction, amino acid substitutions in eight of the 21 amino acids that make up these surfaces cause muscular dystrophy (Leiden muscular dystrophy database http: //www. dmd. nl). It is interesting to note that the largest structural perturbations were observed for the G449V and W514R mutants, which correspond to the most severe patient phenotypes. The corresponding amino acid substitutions in Drosophila Lamin C caused the greatest percentage of lethality [9]. The N456I mutant showed the least structural perturbations in the Ig-fold domain (Fig 1), though the relative severity of symptoms in this patient was not assertained [29]. Consistent with the structural data, the corresponding amino acid substitution in Drosophila Lamin C gave the least percentage of lethality [9]. Thus, our investigations showed an obvious correlation between the severity of the Ig-fold structural perturbations and phenotypic severity. The structural perturbations within the Ig-fold might generate novel interaction surfaces that promote lamin aggregation (Figs 1 and 2A). Both nuclear and cytoplasmic aggregation of mutant lamins have been reported [30,31], however, they are not commonly observed in human muscle biopsy tissue or tissue from a laminopathy mouse model [9,32]. Cytoplasmic aggregation was observed for a truncated form of A-type lamin that causes Hutchinson-Gilford progeria syndrome [30]. Lamin aggregation is supported by X-ray crystallography studies of a R482W substitition in the A-type lamin Ig-fold domain that causes lipodystrophy [33]. The R482W Ig-fold domain possesses unique interaction surfaces not present in the wild type Ig-fold that form a unique platform for tetramerization. The structural perturbations in the Ig-fold domain are likely to affect many functions of the mutant lamins. The lamin Ig-fold domain interacts with many partners to build the network that underlies the inner membrane of the nuclear envelope [5]. Mutant lamins can be inappropriately incorporated into the lamin network and function as dominant negatives [15,34,35]. This is the case for the headless lamin, which has dominant effects on nuclear shape and stiffness in both Drosophila muscle tissue and MEFs (Fig 2) [13]. In contrast, the Ig-fold substitutions do not cause major dominant effects on stiffness, however, there might be undetected alterations in the lamina and/or nuclear organization. Changes in nuclear organization could explain the misregulation of gene expression that we observed in muscles expressing mutant lamins (S1 and S2 Tables). In addition, the amino acid substitutions within the lamin Ig-fold domain might disrupt posttranslational modifications that occur on lamins, similar to what has been shown for familial partial lipodystrophy LMNA mutations that disrupt SUMOylation of Lamin A [36]. Changes in posttranslational modifications have the potential to alter interaction with partner proteins and/or affect aggregation properties. Cytoplasmic protein aggregation has been linked to reductive stress [37,38]. Here, we show that cytoplasmic lamin aggregation correlates with elevated levels of both GSH and NADPH, hallmarks of reductive stress [20] (Fig 3). Elevated levels of isocitrate dehydrogenase enzyme activity (S5 Fig) contribute to the additional NADPH. In a similar manner, dominant negative forms of alphaB-crystallin (CryAB) result in cytoplasmic CryAB misfolding/aggregation and reductive stress in the mouse heart, ultimately leading to dilated cardiomyopathy [39]. These findings suggest that reductive stress might contribute to the dilated cardiomyopathy in cases of lamin associated muscular dystrophy. Interestingly, mutations in the human CRYAB gene cause disease phenotypes that are strikingly similar to those observed for lamin associated muscular dystrophy, including skeletal muscle weakness and dilated cardiomyopathy in cases of lamin-associated muscular dystrophy. It is worthwhile to note that CryAB functions as a chaperone to prevent aggregation of intermediate filament proteins such as desmin, suggesting a common link between intermediate filament aggregation and reductive stress. An imbalance in redox homeostasis can provide an environment that promotes protein misfolding and aggregation. The redox state influences aggregation of lamins; aggregation has been observed under both oxidative and reductive conditions [33,40]. In fact, the formation of the novel tetramer generated by the R482W mutant Ig-fold domain (see above) required a reductive environment [33]. Reductive stress has also been observed in healthy individuals predisposed to Alzheimer disease, a disease of protein aggregation [41]. Alzheimer disease is typically accompanied by oxidative stress, however, lymphocytes from patients carrying an ApoE4 allele that predisposes them to Alzheimer disease show reductive stress. It is hypothesized that continual activation of antioxidant defense systems, such as Nrf2/Keap-1 signaling, becomes exhausted over time, particularly later in life, resulting in the inability to properly defend against oxidative stress. Our redox analysis in Drosophila muscle occurred 24–48 hours post expression of the mutant lamins. Our findings suggest reductive stress at the onset of pathology that could resolve into oxidative stress later in disease progression [42]. Typically lamins are thought to regulate gene expression from inside the nucleus, by interacting with transcription factors and organizing the genome [5,43]. Our data support a novel model in which genes are misregulated as a consequence of mutant lamin aggregation in the cytoplasm. Cytoplasmic lamin aggregates have been found in high molecular weight complexes in cases of liver injury [44]. Such complexes contain nuclear pore proteins, signaling mediators, transcription factors and ribosomal proteins, which are thought to disrupt the normal cellular physiology. Lamin aggregation might also serve a cytoprotective function by facilitating the coalescence of mutant lamin so that the contractile apparatus can properly function. A similar mechanism exists in Huntington’s disease, where sequestration of mutant huntingtin in inclusion bodies correlates with better neuron health [45]. Collectively, our findings continue to support this Drosophila model of laminopathies, as many of the phenotypes discovered here in Drosophila have been validated in human muscle biopsies (Figs 4B and 5B) [9]. It is now possible to use this rapid genetic model to (1) determine if mutations in other domains of lamin produce similar phenotypes and (2) if lamin mutations have similar effects in other tissues, such as the heart. Our data suggest that cytoplasmic lamin aggregation contributes to muscle pathology. Consistent with this idea, increased rates of autophagy suppress phenotypes caused by mutant A-type lamin in cultured cells and mouse models [32,46]. Furthermore, electron microscopy of skeletal muscle biopsies from patients with LMNA mutations showed large perinuclear autophagosomes [47], similar to the localization of lamin aggregates and p62 foci in the Drosophila muscle (Figs 2A and 5A). Thus, the regulation of autophagy, a process that removes both damaged organelles and proteins, might be central to the development of therapies. The Drosophila model will allow for genetic dissection of both the autophagy and reductive stress pathways to identify the key factors responsible for the muscle pathogenesis and its suppression.
LMNA mutations identified in patients were introduced into a wild type copy of the human LMNA gene in a pCR2. 1 vector via site-directed mutagenesis (Quick Change, Stratagene). The sequences of the PCR primers used to make these mutations are listed in S3 Table. DNA fragments encoding amino acids 435 through 552 of human lamin A were amplified using primers containing BamH1 and HindIII sites. The resulting PCR products were cloned into the pQE-30 Xa vector (Qiagen) and the constructs was expressed in M15[pREP4] E. coli cells. Expression was induced by IPTG overnight. Expression of wild type Ig-fold, G449V and W514R yielded protein that was purified by nickel column chromatography followed by Superdex-75 size exclusion chromatography. Expression of N456I and L489P yielded proteins that resided within inclusion bodies. Subsequent purification required denaturing conditions in 8 M urea during purification nickel and Superdex-200 size exclusion chromatography. Material from the monomeric peak eluted from the Superdex-200 column was dialyzed overnight to eliminate the urea and then re-purified on the Superdex-75 size exclusion column. Approximately 30 mg of wild type Ig-fold domain and approximately 8 mg of each mutant were purified per liter of cell culture, as determined spectrophotometrically (Nanodrop, Thermo Scientific). Circular dichroism (CD) data was collected using 1 μM protein in 20 mM phosphate buffer with 100 mM NaCl and 0. 1 mM DTT using a Jasco J815 CD Spectrophotometer. The spectral scan was performed between 190 nm and 280 nm. For T1/2 determination, melting curves were monitored under tryptophan absorbance at 230 nm; samples were heated at the rate of 2°C per minute. All CD experiments were performed in triplicate with independently prepared protein samples. Nuclear magnetic resonance (NMR) spectra were recorded at 20°C on a Bruker 500 or 800 MHz NMR spectrometer (NMR Core Facility, University of Iowa). NMR data were processed using NMRPipe [48] and analyzed using Sparky [49] and/or NMRView [50]. For the wild type Ig-fold domain, 1H, 15N, and 13C resonances of the backbone were assigned using the triple resonance experiments [HNCA, HN (CO) CA, HNCACB, HN (CO) CACB, HNCO, HN (CA) CO, and C (CO) NH-TOCSY] with a 500 uM 15N/13C-labeled sample. All NMR experiments were conducted in a NMR buffer containing 20 mM sodium phosphate (pH 7. 0), 100 mM NaCl, 2 mM DTT, 1 mM EDTA and 0. 1 mM sodium azide. Drosophila stocks were cultured on standard corn meal media at 25°C [51]. Stocks with the wild type and mutant lamin transgenes were previously described [9,15,52]. All lamins were expressed using the Gal4/UAS system and the C57 muscle-specific Gal4 driver stock [10]. Western analysis of protein extract from MEFs was according to published procedures [13]. Western analysis using Drosophila muscle was performed by extracting protein from 10 muscle fillets hand-dissected from third instar larvae in 2X Laemmli grinding buffer (125 mM Tris HCL, pH 6. 8,20% glucerol, 4% SDS, 0. 005% bromophenol blue) plus 10 mM DL-Dithiothreitol. Anti-Drosophila p62 (1: 8,000; kind gift of G. Juhász) and anti-Drosophila tubulin (1: 300,000, Sigma) were used as primary antibodies and detected with anti-rabbit-HRP (1: 400, Sigma) and anti-mouse-HRP (1: 400, Sigma). Nuclear strain analysis of modified and unmodified MEFs was performed as previously described [53]. Nuclear strain analysis of Drosophila muscle was previously described [13]. Total RNA was isolated from hand-dissected body wall muscle from 40 third instar larvae per sample. RNA was purified using Trizol (Ambion) followed by RNAeasy (Qiagen). The RNA was used to generate labeled cRNA and hybridized to Drosophila 2. 0 GeneChip arrays (Affymetrix) (DNA Core Facility, University of Iowa). Triplicate biological samples were analyzed for each genotype. The microarray data were analyzed using the Partek Genomic Suite [54]. Differentially expressed genes were identified using analysis of variance (ANOVA) with a two-fold change in expression and a P value of 0. 05 or higher used as a cut off. Immunohistochemistry of Drosophila larval body wall muscles and human muscle biopsy tissues were performed as previously described [9]. Drosophila larval body wall muscles were stained with affinity purified anti-CncC antibodies (1: 100; gift from H. Deng and T. Kerppola) [24], anti-p62/Ref (2) P (1: 3,000, kind gift of G. Juhász) [55] that was detected with Alexa Fluor 488 goat anti-rabbit (1: 400 dilution; Invitrogen). Filamentous actin was detected with Texas Red Phalloidin (1: 400, Invitrogen). Human muscle biopsy cryosections were obtained from the Iowa Wellstone Muscular Dystrophy Cooperative Research Center and stained according to published procedures [9] with human p62/SQSTM1 (1: 3,000, Sigma) and Nrf2 (1: 300, Santa Cruz Biotech), followed by Alexa Fluor 488 goat anti-rabbit (1: 400, Invitrogen). Filamentous actin was detected with Texas Red Phalloidin (1: 400, Invitrogen). Drosophila larval body wall muscles were hand-dissected from 15 larvae, placed in 200 μl of 5% 5-sulfosalicylic acid and quantitation of reduced glutathione (GSH) and oxidized glutathione disulfide (GSSG) was performed as published [56]. GSSG was determined by adding a 1: 1 mixture of 2-vinylpyridine and ethanol to the samples and incubating for two hours before assaying as described previously [57]. Enzymatic rates were compared to standard curves obtained from control samples. GSH and GSSG amounts were normalized to the protein content of the insoluble pellet from the 5-sulfosalicylic acid treatment, dissolved in 2. 5% SDS in 0. 1N bicarbonate, using the BCA Protein Assay Kit (Thermo Scientific). For measurements of NADPH, larval body wall muscles were hand-dissected from 15 larvae and immediately frozen in liquid nitrogen. Muscle samples were thawed in 170 μl of buffer [100 mM Tris HCl, 10 mM EDTA, 0. 05% Triton X (v/v), pH 7. 6] and sonicated four times for 30 seconds each. Assays were performed according to previous published procedures [58]. Absorbance was read at 310nm using a DU670 Spectrophotometer (Beckman) and enzyme activity was expressed as micromoles of NADPH per milligram of total protein. For measurements of the NADPH-producing enzymes, larval body wall muscles were hand-dissected from 15 larvae and immediately frozen in liquid nitrogen. For assays of G6PD and 6PGD, diethylenetriaminepentaacetic acid (DETAPAC) was added to pellet and the mixture sonicated using a Sonics Vibra-cell sonicator with a cup horn at 20% amplitude. Enzymatic assays were performed according to previous published procedures [59] using 0. 1 M Tris HCl-MgCl2,2mM NADP with either 0. 034 grams of glucose-6-phosphate or 0. 041 grams 6-phosphogluconic acid, pH 8. 0. Absorbance was read at 340 nm using a DU670 Spectrophotometer (Beckman) and enzyme activity was reported as milliunits per milligram of protein. IDH activity was measured according to published procedures [60] using 100mM Tris-HCl, 0. 10 mM NADP, 0. 84 mM MgSO4, and1. 37 mM isocitrate (pH 8. 6). Absorbance was measured at 340 nm, every 9 sec, over 3 minutes at 25°C using a DU670 Spectrophotometer (Beckman) and enzyme activity was expressed as micromoles of NADPH produced per minute per microgram soluble protein X 10,000.
Mutations in the human LMNA gene cause muscular dystrophy that is often accompanied by heart disease. The LMNA gene makes proteins that form a network on the inner side of the nuclear envelope, a structure that reinforces the cell nucleus. How mutations in the LMNA gene cause muscle disease is not well understood. Our studies provide evidence that LMNA mutations activate an intracellular signaling pathway and alter the redox homeostasis of muscle tissue. Thus, our results suggest that blocking the signaling pathway and maintaining the oxidative state of the diseased muscle are potential therapies for muscular dystrophy patients with LMNA mutations.
Myopathic Lamin Mutations Cause Reductive Stress and Activate the Nrf2/Keap-1 Pathway